EP4045533
Mennsk einklóna mótefni gegn heilkennum alvarlegrar bráðrar lungnabólgu – kórónuveiru 2 (SARS-CoV-2)
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.3.2021EP published:
15.11.2023EP application number:
21719462.0
EP translation filed:
5.2.2024Grant published:
15.3.2024EPO information:
European Patent Register
Max expiry date:
24.3.2041Expiry date:
24.3.2027Next due date:
31.3.2027
Title in English:
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)Language of the patent:
English
Timeline
Today
25.3.2021EP application
15.11.2023EP Publication
5.2.2024Translation submitted
15.3.2024Registration published
24.3.2027Expires
Owner
Name:
Vanderbilt UniversityAddress:
305 Kirkland Hall 2201 West End Avenue, Nashville, TN 37240, US
Inventor
Name:
CROWE, James E., Jr.Address:
Nashville, Tennessee 37212, US
Name:
ZOST, SethAddress:
Nashville, Tennessee 37232, US
Name:
CARNAHAN, RobertAddress:
Nashville, Tennessee 37232, US
Name:
GILCHUK, PavloAddress:
Nashville, Tennessee 37232, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
202063000299 PDate:
26.3.2020Country:
US
Number:
202063002896 PDate:
31.3.2020Country:
US
Number:
202063003716 PDate:
1.4.2020Country:
US
Number:
202063023545 PDate:
12.5.2020Country:
US
Number:
202063024204 PDate:
13.5.2020Country:
US
Number:
202063024248 PDate:
13.5.2020Country:
US
Number:
202063027173 PDate:
19.5.2020Country:
US
Number:
202063037984 PDate:
11.6.2020Country:
US
Number:
202063040224 PDate:
17.6.2020Country:
US
Number:
202063040246 PDate:
17.6.2020Country:
US
Number:
202163142196 PDate:
27.1.2021Country:
US
Number:
202163161890 PDate:
16.3.2021Country:
US
Classification
Categories:
C07K 16/10, G01N 33/569, G01N 33/577, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 26.3.2024
Expires: 24.3.2025
Payer: Árnason Faktor ehf.
Number: 5
Paid: 12.3.2025
Expires: 24.3.2026
Payer: Árnason Faktor ehf.
Number: 6
Paid: 20.3.2026
Expires: 24.3.2027
Payer: Árnason Faktor ehf.